Abstract
Myofibroblasts have characteristics of fibroblasts and smooth muscle cells: they produce extracellular matrix and are able to contract. In so doing, they can contribute to tissue replacement and interstitial fibrosis following cardiac injury. The scar formed after myocardial injury is no longer considered to be passive tissue; it is an active playground where myofibroblasts play a role in collagen turnover and scar contraction. Maintaining the extracellular matrix in the scar is essential and can prevent dilatation of the infarct area leading to heart failure. On the other hand, extracellular matrix deposition at sites remote from the infarct area can lead to cardiac stiffness, an inevitable process of myocardial remodeling that occurs in the aftermath of myocardial infarction and constitutes the basis of the development of heart failure. Defining molecular targets on myofibroblasts in conjunction with establishing the feasibility of molecular imaging of these cells might facilitate the early detection and treatment of patients who are at risk of developing heart failure after myocardial infarction.
Key Points
-
Myofibroblasts have characteristics of fibroblasts and smooth muscle cells and contribute to tissue replacement and interstitial fibrosis following cardiac injury
-
Maintaining the extracellular matrix in the scar is essential and can prevent dilatation of the infarct area
-
Extracellular matrix deposition at sites remote from the infarct area can contribute to the development of cardiac remodeling and heart failure
-
Defining molecular targets on myofibroblasts in conjunction with establishing the feasibility of molecular imaging might facilitate early detection and treatment of patients at risk of developing heart failure after myocardial infarction
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hein, S. & Schaper, J. The extracellular matrix in normal and diseased myocardium. J. Nucl. Cardiol. 8, 188–196 (2001).
Medugorac, I. Characterization of intramuscular collagen in mammalian left ventricle. Basic Res. Cardiol. 77, 589–598 (1982).
Camelliti, P., Borg, T. K. & Kohl, P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 65, 40–51 (2005).
Porter, K. E. & Turner, N. A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123, 255–278 (2009).
Leask, A. & Abraham, D. J. TGF-beta signaling and the fibrotic response. FASEB J. 18, 816–827 (2004).
Prockop, D. J. & Kivirikko, K. I. Collagens: molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 64, 403–434 (1995).
Kagan, H. M. & Trackman, P. C. Properties and function of lysyl oxidase. Am. J. Respir. Cell. Mol. Biol. 5, 206–210 (1991).
Shapiro, S. D. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10, 602–608 (1998).
Cleutjens, J. P., Blankesteijn, W. M., Daemen, M. J. & Smits, J. F. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc. Res. 44, 232–241 (1999).
Brown, R. D., Ambler, S. K., Mitchell, M. D. & Long, C. S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharmacol. Toxicol. 45, 657–687 (2005).
Wynn, T. A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199–210 (2008).
Kalluri, R. & Neilson, E. G., Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776–1784 (2003).
Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952–961 (2007).
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M. & Cerami, A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1, 71–81 (1994).
Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110, 341–350 (2002).
Chang, H. Y. et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl Acad. Sci. USA 99, 12877–12882 (2002).
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3, 349–363 (2002).
Squires, C. E. et al. Altered fibroblast function following myocardial infarction. J. Mol. Cell Cardiol. 39, 699–707 (2005).
Hinz, B. & Gabbiani, G. Mechanisms of force generation and transmission by myofibroblasts. Curr. Opin. Biotechnol. 14, 538–546 (2003).
Serini, G. et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J. Cell Biol. 142, 873–881 (1998).
Wang, J., Chen, H., Seth, A. & McCulloch, C. A. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 285, H1871–H1881 (2003).
Muro, A. F. et al. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J. Cell Biol. 162, 149–160 (2003).
Hinz, B. Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur. J. Cell Biol. 85, 175–181 (2006).
Asano, Y. et al. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J. Immunol. 175, 7708–7718 (2005).
Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500–503 (2003).
Virag, J. I. & Murry, C. E. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am. J. Pathol. 163, 2433–2440 (2003).
Foo, I. T., Naylor, I. L., Timmons, M. J. & Trejdosiewicz, L. K. Intracellular actin as a marker for myofibroblasts in vitro. Lab. Invest. 67, 727–733 (1992).
Hinz, B. et al. The myofibroblast: one function, multiple origins. Am. J. Pathol. 170, 1807–1816 (2007).
van Eys, G. J., Niessen, P. M. & Rensen, S. S. Smoothelin in vascular smooth muscle cells. Trends Cardiovasc. Med. 17, 26–30 (2007).
Chambers, R. C., Leoni, P., Kaminski, N., Laurent, G. J. & Heller, R. A. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am. J. Pathol. 162, 533–546 (2003).
Ronty, M. J. et al. Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation. J. Invest. Dermatol. 126, 2387–2396 (2006).
Mykkanen, O. M. et al. Characterization of human palladin, a microfilament-associated protein. Mol. Biol. Cell 12, 3060–3073 (2001).
Paine, R., 3rd & Ward, P. A. Cell adhesion molecules and pulmonary fibrosis. Am. J. Med. 107, 268–279 (1999).
Kuncio, G. S., Neilson, E. G. & Haverty, T. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 39, 550–556 (1991).
Blankesteijn, W. M., Essers-Janssen, Y. P., Verluyten, M. J., Daemen, M. J. & Smits, J. F. A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart. Nat. Med. 3, 541–544 (1997).
Cleutjens, J. P., Verluyten, M. J., Smiths, J. F. & Daemen, M. J. Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 147, 325–338 (1995).
Smith-Mungo, L. I. & Kagan, H. M. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 16, 387–398 (1998).
Hong, H. H., Uzel, M. I., Duan, C., Sheff, M. C. & Trackman, P. C. Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab. Invest. 79, 1655–1667 (1999).
Gabbiani, G., Hirschel, B. J., Ryan, G. B., Statkov, P. R. & Majno, G. Granulation tissue as a contractile organ. A study of structure and function. J. Exp. Med. 135, 719–734 (1972).
Desmouliere, A., Redard, M., Darby, I. & Gabbiani, G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146, 56–66 (1995).
Willems, I. E., Havenith, M. G., De Mey, J. G. & Daemen, M. J. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am. J. Pathol. 145, 868–875 (1994).
Sun, Y., Kiani, M. F., Postlethwaite, A. E. & Weber, K. T. Infarct scar as living tissue. Basic Res. Cardiol. 97, 343–347 (2002).
Li, Y. et al. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ. Res. 95, 627–636 (2004).
von Harsdorf, R. “Fas-ten” your seat belt: anti-apoptotic treatment in heart failure takes off. Circ. Res. 95, 554–556 (2004).
Okada, H. et al. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 111, 2430–2437 (2005).
Kanamori, H. et al. Inhibition of Fas-associated apoptosis in granulation tissue cells accompanies attenuation of postinfarction left ventricular remodeling by olmesartan. Am. J. Physiol. Heart Circ. Physiol. 292, H2184–2194 (2007).
Petridou, S., Maltseva, O., Spanakis, S. & Masur, S. K. TGF-beta receptor expression and smad2 localization are cell density dependent in fibroblasts. Invest. Ophthalmol. Vis. Sci. 41, 89–95 (2000).
Opie, L. H., Commerford, P. J., Gersh, B. J. & Pfeffer, M. A. Controversies in ventricular remodelling. Lancet 367, 356–367 (2006).
Schocken, D. D. et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 117, 2544–2565 (2008).
Beltrami, C. A. et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89, 151–163 (1994).
Weber, K. T., Sun, Y. & Katwa, L. C. Myofibroblasts and local angiotensin II in rat cardiac tissue repair. Int. J. Biochem. Cell Biol. 29, 31–42 (1997).
Harada, K., Sugaya, T., Murakami, K., Yazaki, Y. & Komuro, I. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 100, 2093–2099 (1999).
Pfeffer, M. A. et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362, 759–766 (2003).
Pitt, B. et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet 355, 1582–1587 (2000).
Cohn, J. N. & Tognoni, G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 345, 1667–1675 (2001).
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N. Engl. J. Med. 316, 1429–1435 (1987).
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N. Engl. J. Med. 325, 293–302 (1991).
Rosenkranz, S. et al. Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am. J. Physiol. Heart Circ. Physiol. 283, H1253–H1262 (2002).
van den Borne, S. W. et al. Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J. Am. Coll. Cardiol. 52, 2017–2028 (2008).
Landmesser, U., Wollert, K. C. & Drexler, H. Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc. Res. 81, 519–527 (2009).
Katz, A. M. The cardiomyopathy of overload: an unnatural growth response. Eur. Heart J. 16 (Suppl. O), 110–114 (1995).
Rosamond, W. et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25–146 (2008).
Weisman, H. F., Bush, D. E., Mannisi, J. A., Weisfeldt, M. L. & Healy, B. Cellular mechanisms of myocardial infarct expansion. Circulation 78, 186–201 (1988).
Gaasch, W. H. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA 271, 1276–1280 (1994).
Pfeffer, M. A. & Braunwald, E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81, 1161–1172 (1990).
van den Borne, S. W. et al. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc. Res. 84, 273–282 (2009).
Eyden, B. The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. J. Submicrosc. Cytol. Pathol. 7–166 (2007).
Verjans, J. W. H. et al. Noninvasive imaging of angiotensin receptores after myocardial infarction. J. Am. Coll. Cardiol. Cardiovasc. Imaging 1, 354–362 (2008).
Ng, C. P., Hinz, B. & Swartz, M. A. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J. Cell Sci. 118, 4731–4739 (2005).
Verjans, J. W. et al. Imaging avb3/b5 integrin upregulation in patients after myocardial infarction [abstract 3288]. Circulation 116, II_740 (2007).
Pho, M. et al. Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves. Am. J. Physiol. Heart Circ. Physiol. 294, H1767–H1778 (2008).
Gerthoffer, W. T. Mechanisms of vascular smooth muscle cell migration. Circ. Res. 100, 607–621 (2007).
Hinz, B. Formation and function of the myofibroblast during tissue repair. J. Invest. Dermatol. 127, 526–537 (2007).
Yamamoto, Y., Kubota, T., Atoji, Y. & Suzuki, Y. Distribution of alpha-vascular smooth muscle actin in the smooth muscle cells of the gastrointestinal tract of the chicken. J. Anat. 189 (Pt 3), 623–630 (1996).
Rosenkranz, S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc. Res. 63, 423–432 (2004).
Urbich, C. & Dimmeler, S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95, 343–353 (2004).
Castoldi, G. et al. Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells. Clin. Sci. (Lond.) 108, 523–530 (2005).
Glukhova, M. A. et al. Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent. J. Cell Biol. 109, 357–366 (1989).
Reynaud, C., Gleyzal, C., Jourdan-Le Saux, C. & Sommer, P. Comparative functional study of the lysyl oxidase promoter in fibroblasts, Ras-transformed fibroblasts, myofibroblasts and smooth muscle cells. Cell. Mol. Biol. (Noisy-le-grand) 45, 1237–1247 (1999).
Zannad, F., Alla, F., Dousset, B., Perez, A. & Pitt, B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 102, 2700–2706 (2000).
Acknowledgements
This article is dedicated to the memory of the late Lovhaug Dagfinn, PhD, who helped to develop the RGD imaging agents described herein for myofibroblast imaging. The authors also gratefully acknowledge all their colleagues for their contributions in this research area.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
van den Borne, S., Diez, J., Blankesteijn, W. et al. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7, 30–37 (2010). https://doi.org/10.1038/nrcardio.2009.199
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2009.199
This article is cited by
-
The additive prognostic value of end-systolic pressure-volume relation by stress CMR in patients with known or suspected coronary artery disease
The International Journal of Cardiovascular Imaging (2024)
-
Early detection of radiation-induced myocardial damage by [18F]AlF-NOTA-FAPI-04 PET/CT imaging
European Journal of Nuclear Medicine and Molecular Imaging (2023)
-
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
Cell & Bioscience (2022)
-
Alamandine alleviated heart failure and fibrosis in myocardial infarction mice
Biology Direct (2022)
-
The scar: the wind in the perfect storm—insights into the mysterious living tissue originating ventricular arrhythmias
Journal of Interventional Cardiac Electrophysiology (2022)